Scheiflinger, Friedrich
Takeda (Austria)
4 papers on CoChatORCID 0000-0003-0101-9187
Most cited papers
- Verified
BAX 335 hemophilia b gene therapy clinical trial results: Potential impact of CpG sequences on gene expression
Konkle, B. A., Walsh, C. E., Escobar, M. A., Josephson, N. C., Young, G., von Drygalski, A., McPhee, S. W. J., Samulski, R. J., Bilic, I., de la Rosa, M., et al. (2021) · Blood
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 189
- Verified
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Kruzik, A., Fetahagic, D., Hartlieb, B., Dorn, S., Koppensteiner, H., Horling, F. M., Scheiflinger, F., Reipert, B. M., & de la Rosa, M. (2019) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 182
- Verified
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
Milani, M., Annoni, A., Bartolaccini, S., Biffi, M., Russo, F., Di Tomaso, T., Raimondi, A., Lengler, J., Holmes, M. C., Scheiflinger, F., et al. (2017) · EMBO Molecular Medicine
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 72
- Verified
Blockade of the costimulatory CD28‐B7 family signal axis enables repeated application of AAV8 gene vectors
Frentsch, M., Japp, A. S., Dingeldey, M., Matzmohr, N., Thiel, A., Scheiflinger, F., Reipert, B. M., & de la Rosa, M. (2020) · Journal of Thrombosis and Haemostasis
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free